Celestial Biolabs has launched a new product ‘Cadalmin GAe' which is a break through research in the management of joint paints of any aetiology. Cadalmin GAe provides relief to people suffering from Arthritis, Lumbago, Gout, Rheumatoid, Low back ache, Sciatica etc. This product is developed at CMFRI (Central Marine Fisheries Research Institute) a prestigious institute of Indian Council of Agricultural Research. This new product is a result of Experimental & clinical study exhibited Cadalmin GAe to be Mother Nature's first ever effective, well tolerated, safe research molecule devoid of harmful side effects.
Celestial Biolabs (CBL) has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research. CBL also involved in the R&D, commercial production and marketing of enzymes, nutraceuticals. Celestial Biolabs is setting up a biotechnology facility in Genome Valley at Hyderabad, India to manufacture its own drug molecules, industrial enzymes and to contract research activities.
